Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Longoria

Thoracic Surgery (Cardiothoracic Vascular Surgery) Sacramento, CA Medical Doctor

NPI 1306845888 CMS profile 194775

2800 L St Ste 200, Sacramento, CA 95816

Open in the dashboard

General payments

$36,334

170 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$20,680 paid to institutions, not to them · program years 2019–2020

Through program year 2025, James Longoria of Sacramento, CA is reported in the CMS Open Payments database as having received $36,334 across 170 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $20,680 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $666 23
2024 General $5,429 19
2023 General $1,018 16
2022 General $1,614 15
2021 General $13,894 31
2020 General $11,373 30
2019 General $2,339 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Longoria
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to James Longoria were reported at $666. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year James Longoria Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $2,339 $886 $178–$3,167 $163
2020 $11,373 $341 $108–$1,605 $114
2021 $13,894 $453 $125–$1,886 $132
2022 $1,614 $695 $180–$2,566 $149
2023 $1,018 $745 $205–$2,662 $160
2024 $5,429 $799 $214–$2,967 $164
2025 $666 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $33,254 81 payments
  2. Edwards Lifesciences Corporation $625 22 payments
  3. Abbott Laboratories $614 6 payments
  4. Medtronic Vascular, Inc. $486 18 payments
  5. Medtronic, Inc. $381 12 payments
  6. CryoLife, Inc. $168 2 payments
  7. LivaNova USA, Inc. $150 6 payments
  8. Maquet Cardiovascular U.S. Sales, L.L.C. $123 6 payments
  9. Covidien LP $110 3 payments
  10. Abiomed $90 4 payments
  11. Other $333 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $30,500 24 payments
  2. Food and Beverage $4,298 138 payments
  3. Travel and Lodging $1,000 6 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
  5. Education $35 1 payment
Products named General payments · program years 2019–2025
  1. SYNERGY ABLATION SYSTEM $15,565 33 payments
  2. ATRICLIP LAA EXCLUSION SYSTEM $14,255 45 payments
  3. DISSECTOR $13,285 13 payments
  4. ISOLATOR SURGICAL ABLATION SYSTEM Cardiovascular $10,875 14 payments
  5. ATRICURE SYNERGY ABLATION SYSTEM $6,199 12 payments
  6. ATRICURE ATRICLIP LAA EXCLUSION $5,182 9 payments
  7. Trifecta GT Tissue Heart Valve $567 4 payments
  8. ISOLATOR SURGICAL ABLATION SYSTEM Cardiovascular $519 16 payments
  9. SAPIEN 3 Ultra RESILIA $399 16 payments
  10. 3F $266 11 payments
  11. Other $2,835 84 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$161,657

Medicare's payments for the services billed

Medicare patients

130

Average age 75

Services billed

328

41 women, 89 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 73%
Atrial fibrillation 70%
Heart failure 60%
Chronic kidney disease 59%
Diabetes 48%
Arthritis 46%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

170 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record